| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |